Literature DB >> 20166753

Structural analysis and functional implications of the negative mTORC1 regulator REDD1.

Silvia Vega-Rubin-de-Celis1, Zeina Abdallah, Lisa Kinch, Nick V Grishin, James Brugarolas, Xuewu Zhang.   

Abstract

REDD1 is a conserved stress-response protein that regulates mTORC1, a critical regulator of cell growth and proliferation that is implicated in cancer. REDD1 is induced by hypoxia, and REDD1 overexpression is sufficient to inhibit mTORC1. mTORC1 is regulated by the small GTPase Rheb, which in turn is regulated by the GTPase-activating protein complex, TSC1/TSC2. REDD1 induced-mTORC1 inhibition requires the TSC1/TSC2 complex, and REDD1 has been proposed to act by directly binding to and sequestering 14-3-3 proteins away from TSC2 leading to TSC2-dependent inhibition of mTORC1. Structure/function analyses have led us to identify two segments in REDD1 that are essential for function, which act in an interdependent manner. We have determined a crystal structure of REDD1 at 2.0 A resolution, which shows that these two segments fold together to form an intact domain with a novel fold. This domain is characterized by an alpha/beta sandwich consisting of two antiparallel alpha-helices and a mixed beta-sheet encompassing an uncommon psi-loop motif. Structure-based docking and functional analyses suggest that REDD1 does not directly bind to 14-3-3 proteins. Sequence conservation mapping to the surface of the structure and mutagenesis studies demarcated a hotspot likely to interact with effector proteins that is essential for REDD1-mediated mTORC1 inhibition.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20166753      PMCID: PMC3046781          DOI: 10.1021/bi902135e

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  46 in total

Review 1.  14-3-3 proteins: active cofactors in cellular regulation by serine/threonine phosphorylation.

Authors:  Guri Tzivion; Joseph Avruch
Journal:  J Biol Chem       Date:  2001-11-14       Impact factor: 5.157

2.  PHENIX: building new software for automated crystallographic structure determination.

Authors:  Paul D Adams; Ralf W Grosse-Kunstleve; Li Wei Hung; Thomas R Ioerger; Airlie J McCoy; Nigel W Moriarty; Randy J Read; James C Sacchettini; Nicholas K Sauter; Thomas C Terwilliger
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-10-21

3.  Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action.

Authors:  Kenta Hara; Yoshiko Maruki; Xiaomeng Long; Ken-ichi Yoshino; Noriko Oshiro; Sujuti Hidayat; Chiharu Tokunaga; Joseph Avruch; Kazuyoshi Yonezawa
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

4.  DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival.

Authors:  Timothy R Peterson; Mathieu Laplante; Carson C Thoreen; Yasemin Sancak; Seong A Kang; W Michael Kuehl; Nathanael S Gray; David M Sabatini
Journal:  Cell       Date:  2009-05-14       Impact factor: 41.582

5.  Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control.

Authors:  Robbie Loewith; Estela Jacinto; Stephan Wullschleger; Anja Lorberg; José L Crespo; Débora Bonenfant; Wolfgang Oppliger; Paul Jenoe; Michael N Hall
Journal:  Mol Cell       Date:  2002-09       Impact factor: 17.970

6.  REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species.

Authors:  Leif W Ellisen; Kate D Ramsayer; Cory M Johannessen; Annie Yang; Hideyuki Beppu; Karolina Minda; Jonathan D Oliner; Frank McKeon; Daniel A Haber
Journal:  Mol Cell       Date:  2002-11       Impact factor: 17.970

7.  TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling.

Authors:  Ken Inoki; Yong Li; Tianquan Zhu; Jun Wu; Kun-Liang Guan
Journal:  Nat Cell Biol       Date:  2002-09       Impact factor: 28.824

8.  Akt regulates growth by directly phosphorylating Tsc2.

Authors:  Christopher J Potter; Laura G Pedraza; Tian Xu
Journal:  Nat Cell Biol       Date:  2002-09       Impact factor: 28.824

9.  mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery.

Authors:  Do-Hyung Kim; D D Sarbassov; Siraj M Ali; Jessie E King; Robert R Latek; Hediye Erdjument-Bromage; Paul Tempst; David M Sabatini
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

10.  Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway.

Authors:  Brendan D Manning; Andrew R Tee; M Nicole Logsdon; John Blenis; Lewis C Cantley
Journal:  Mol Cell       Date:  2002-07       Impact factor: 17.970

View more
  36 in total

Review 1.  Regulation of mammalian target of rapamycin complex 1 (mTORC1) by hypoxia: causes and consequences.

Authors:  Hakan Cam; Peter J Houghton
Journal:  Target Oncol       Date:  2011-04-16       Impact factor: 4.493

2.  DDiT4L promotes autophagy and inhibits pathological cardiac hypertrophy in response to stress.

Authors:  Bridget Simonson; Vinita Subramanya; Mun Chun Chan; Aifeng Zhang; Hannabeth Franchino; Filomena Ottaviano; Manoj K Mishra; Ashley C Knight; Danielle Hunt; Ionita Ghiran; Tejvir S Khurana; Maria I Kontaridis; Anthony Rosenzweig; Saumya Das
Journal:  Sci Signal       Date:  2017-02-28       Impact factor: 8.192

3.  Multistep regulation of TFEB by MTORC1.

Authors:  Silvia Vega-Rubin-de-Celis; Samuel Peña-Llopis; Meghan Konda; James Brugarolas
Journal:  Autophagy       Date:  2017-01-05       Impact factor: 16.016

Review 4.  Alcoholic Cardiomyopathy: Disrupted Protein Balance and Impaired Cardiomyocyte Contractility.

Authors:  Jennifer L Steiner; Charles H Lang
Journal:  Alcohol Clin Exp Res       Date:  2017-05-29       Impact factor: 3.455

5.  Quantitative Lys-ϵ-Gly-Gly (diGly) proteomics coupled with inducible RNAi reveals ubiquitin-mediated proteolysis of DNA damage-inducible transcript 4 (DDIT4) by the E3 ligase HUWE1.

Authors:  Joel W Thompson; Jane Nagel; Sjouke Hoving; Bertran Gerrits; Andreas Bauer; Jason R Thomas; Marc W Kirschner; Markus Schirle; Sarah J Luchansky
Journal:  J Biol Chem       Date:  2014-08-21       Impact factor: 5.157

Review 6.  Emerging role for regulated in development and DNA damage 1 (REDD1) in the regulation of skeletal muscle metabolism.

Authors:  Bradley S Gordon; Jennifer L Steiner; David L Williamson; Charles H Lang; Scot R Kimball
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-05-17       Impact factor: 4.310

7.  REDD1/DDIT4-independent mTORC1 inhibition and apoptosis by glucocorticoids in thymocytes.

Authors:  Nicholas C Wolff; Renée M McKay; James Brugarolas
Journal:  Mol Cancer Res       Date:  2014-03-10       Impact factor: 5.852

Review 8.  mTOR inhibitors in urinary bladder cancer.

Authors:  R Pinto-Leite; R Arantes-Rodrigues; Nuno Sousa; P A Oliveira; L Santos
Journal:  Tumour Biol       Date:  2016-05-27

9.  Platelet-derived growth factor/vascular endothelial growth factor receptor inactivation by sunitinib results in Tsc1/Tsc2-dependent inhibition of TORC1.

Authors:  Tram Anh Tran; Lisa Kinch; Samuel Peña-Llopis; Lutz Kockel; Nick Grishin; Huaqi Jiang; James Brugarolas
Journal:  Mol Cell Biol       Date:  2013-07-22       Impact factor: 4.272

10.  REDD1 enhances protein phosphatase 2A-mediated dephosphorylation of Akt to repress mTORC1 signaling.

Authors:  Michael D Dennis; Catherine S Coleman; Arthur Berg; Leonard S Jefferson; Scot R Kimball
Journal:  Sci Signal       Date:  2014-07-22       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.